GrowBLOX Sciences is Making Big Moves in Anticipation of Opening Nevada Cultivation Facility

LAS VEGAS, July 23, 2015 (GLOBE NEWSWIRE) -- GrowBLOX Sciences, Inc. (OTCQB:GBLX), a biopharmaceutical company with state-of-the-art technologies in plant biology and cultivation designed to produce consistent medicinal cannabis, today announced that over the course of the next few weeks certain changes in management personnel and operating procedures would soon be implemented in preparation for the commencement of cultivation operations through our majority-owned subsidiary, GB Sciences Nevada, LLC.

CEO Craig Ellins shared that “The build out of our principal cultivation facility in Nevada is proceeding well and on schedule. As we transition from our engineering intensive development stage, involving largely R&D and licensure efforts, to the day-to-day operations of producing an excellent product, branding it appropriately, and maximizing our revenue, we will need to significantly beef up our staff.  We have brought in John Poss as a...